UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase

The Journal of biological chemistry, 2005-09, Vol.280 (35), p.31182-31189

2005

Volltextzugriff (PDF)

Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive Radiotherapy

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3370-3378

2009

Volltextzugriff (PDF)

The epidermal growth factor receptor mediates radioresistance

International journal of radiation oncology, biology, physics, 2003-09, Vol.57 (1), p.246-254

2003

Volltextzugriff (PDF)

Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

Clinical cancer research, 2011-04, Vol.17 (7), p.1815-1827

2011

Volltextzugriff (PDF)

Cancer Stem Cells and Tumor Response to Therapy: Current Problems and Future Prospects

Seminars in radiation oncology, 2009-04, Vol.19 (2), p.96-105

2009

Volltextzugriff (PDF)

Use of Molecular Biomarkers for Predicting the Response to Radiotherapy With or Without Chemotherapy

Journal of clinical oncology, 2007-09, Vol.25 (26), p.4075-4083

2007

Volltextzugriff (PDF)

Sensitization of breast cancer cells to radiation by trastuzumab

Molecular cancer therapeutics, 2003-11, Vol.2 (11), p.1113-1120

2003

Volltextzugriff (PDF)

In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody

Clinical cancer research, 2000-02, Vol.6 (2), p.701-708

2000

Volltextzugriff (PDF)

Mitigation and Treatment of Radiation-Induced Thoracic Injury With a Cyclooxygenase-2 Inhibitor, Celecoxib

International journal of radiation oncology, biology, physics, 2013-02, Vol.85 (2), p.472-476

2013

Volltextzugriff (PDF)

Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy

Clinical cancer research, 2005-01, Vol.11 (1), p.361-369

2005

Volltextzugriff (PDF)

Combination of Anti-IGF-1R Antibody A12 and Ionizing Radiation in Upper Respiratory Tract Cancers

International journal of radiation oncology, biology, physics, 2011-03, Vol.79 (4), p.1179-1187

2011

Volltextzugriff (PDF)

Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas

Clinical cancer research, 1999-10, Vol.5 (10), p.2884-2890

1999

Volltextzugriff (PDF)

The role of apoptosis in radiation oncology

International journal of radiation biology, 2009-01, Vol.85 (2), p.107-115

2009

Volltextzugriff (PDF)

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse

Radiotherapy and oncology, 2010-07, Vol.96 (1), p.108-115

2010

Volltextzugriff (PDF)

Celecoxib Induced Tumor Cell Radiosensitization by Inhibiting Radiation Induced Nuclear EGFR Transport and DNA-Repair: A COX-2 Independent Mechanism

International journal of radiation oncology, biology, physics, 2008, Vol.70 (1), p.203-212

2008

Volltextzugriff (PDF)

130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain

Clinical cancer research, 2007-03, Vol.13 (6), p.1868-1874

2007

Volltextzugriff (PDF)

Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (4), p.974-984

2007

Volltextzugriff (PDF)

Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation

International journal of radiation oncology, biology, physics, 2007-02, Vol.67 (2), p.568-572

2007

Volltextzugriff (PDF)

Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor

Clinical cancer research, 2000-06, Vol.6 (6), p.2513-2520

2000

Volltextzugriff (PDF)

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors

International journal of radiation oncology, biology, physics, 2004-02, Vol.58 (2), p.369-375

2004

Volltextzugriff (PDF)

Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib

International journal of radiation oncology, biology, physics, 2005-10, Vol.63 (2), p.520-528

2005

Volltextzugriff (PDF)

Targeted Therapy Against VEGFR and EGFR With ZD6474 Enhances the Therapeutic Efficacy of Irradiation in an Orthotopic Model of Human Non–Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2007-12, Vol.69 (5), p.1534-1543

2007

Volltextzugriff (PDF)

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Clinical cancer research, 2005-05, Vol.11 (9), p.3342-3348

2005

Volltextzugriff (PDF)

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of Cyclooxygenase-2 enzyme: mechanistic considerations

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.886-894

2002

Volltextzugriff (PDF)

Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (3), p.870-878

2007

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(206)
Animals
(188)
Oncology
(180)
Mice
(168)
Biological And Medical Sciences
(137)
Medical Sciences
(119)
Mice, Inbred C3h
(105)
Female
(93)
Humans
(93)
Radiology, Nuclear Medicine & Medical Imaging
(89)
Male
(85)
Tumors
(71)
Pharmacology. Drug Treatments
(51)
Antineoplastic Agents
(50)
Combined Modality Therapy
(49)
Neoplasm Transplantation
(42)
Apoptosis
(36)
Radiotherapy
(34)
Dose-Response Relationship, Radiation
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase

Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive Radiotherapy

The epidermal growth factor receptor mediates radioresistance

Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro

Cancer Stem Cells and Tumor Response to Therapy: Current Problems and Future Prospects

Use of Molecular Biomarkers for Predicting the Response to Radiotherapy With or Without Chemotherapy

Sensitization of breast cancer cells to radiation by trastuzumab

In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody

Mitigation and Treatment of Radiation-Induced Thoracic Injury With a Cyclooxygenase-2 Inhibitor, Celecoxib

Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy

Combination of Anti-IGF-1R Antibody A12 and Ionizing Radiation in Upper Respiratory Tract Cancers

Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas

The role of apoptosis in radiation oncology

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse

Celecoxib Induced Tumor Cell Radiosensitization by Inhibiting Radiation Induced Nuclear EGFR Transport and DNA-Repair: A COX-2 Independent Mechanism

130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain

Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck Cancer

Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation

Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors

Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib

Targeted Therapy Against VEGFR and EGFR With ZD6474 Enhances the Therapeutic Efficacy of Irradiation in an Orthotopic Model of Human Non–Small-Cell Lung Cancer

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of Cyclooxygenase-2 enzyme: mechanistic considerations

Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice

Suchergebnisse filtern